Transfusion‐Associated Graft‐Versus‐Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?

Klaus Schmierer, Frederick Chen, David Paling

Open source

DOI
10.1111/ene.70698
Published
2026-07
Container
European Journal of Neurology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/ene.70698,
  title = {Transfusion‐Associated Graft‐Versus‐Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?},
  author = {Klaus Schmierer and Frederick Chen and David Paling},
  year = {2026},
  journal = {European Journal of Neurology},
  doi = {10.1111/ene.70698},
  url = {https://doi.org/10.1111/ene.70698}
}

RIS

TY  - JOUR
TI  - Transfusion‐Associated Graft‐Versus‐Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?
AU  - Klaus Schmierer
AU  - Frederick Chen
AU  - David Paling
PY  - 2026
JO  - European Journal of Neurology
DO  - 10.1111/ene.70698
UR  - https://doi.org/10.1111/ene.70698
ER  - 

APA

Schmierer, K., Chen, F., & Paling, D. (2026). Transfusion‐Associated Graft‐Versus‐Host Disease Risk and Transfusion Requirements After Cladribine in Multiple Sclerosis: Time to Revise Irradiation Policy?. European Journal of Neurology. https://doi.org/10.1111/ene.70698

Source records